Haemophilia: open trials in Poland

7 open trials have a site in Poland. Registry data; only the trial team decides who can take part.

NCT05987449
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Trial Treatment · Phase 1/2 · Hoffmann-La Roche
Uniwersyteckie Centrum Kliniczne, Gdansk · Instytut Hematologii I Transfuzjologii, Warsaw
Registry updated 2026-11-05
NCT07416604
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Trial Treatment · Phase 3 · Hoffmann-La Roche
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie, Cracow · Uniwersyteckie Centrum Kliniczne, Gdansk · Instytut Hematologii I Transfuzjologii, Warsaw
Registry updated 2026-11-03
NCT07830732
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Trial Treatment · Phase 3 · Novo Nordisk A/S
Uniwersyteckie Centrum Kliniczne, Gdansk · Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, Lodz · Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan · Instytut Hematologii I Transfuzjologii, Warsaw
Registry updated 2026-10-28
NCT07285460
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Trial Treatment · Phase 3 · Sanofi
Szpital Kliniczny Im. Karola Jonschera Uniwersytetu Medycznego Im. Karola Marcinkowskiego W Poznaniu, Poznan · Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Warsaw · Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we Wroclawiu, Wroclaw
Registry updated 2026-10-27
NCT07416526
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Trial Treatment · Phase 3 · Hoffmann-La Roche
Uniwersyteckie Centrum Kliniczne, Gdansk · Instytut Hematologii I Transfuzjologii, Warsaw
Registry updated 2026-10-26
NCT07220564
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Trial Treatment · Phase 1 · Novo Nordisk A/S
Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok · Uniwersyteckie Centrum Kliniczne, Gdansk · Samodzielny Publiczny Szpital Kliniczny Im.Andrzeja Mieleckiego Slaskiego Uniwersytetu Medycznego W Katowicach, Katowice · Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie, Lublin · Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan · Instytut Hematologii I Transfuzjologii, Warsaw
Registry updated 2026-09-18
NCT06003387
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
Trial Treatment · Phase 3 · CSL Behring
Instytut Hematologii I Transfuzjologii, Warsaw
Registry updated 2026-08-27

All Haemophilia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Haemophilia: open trials in Poland

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A

A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)